ANIP | Stephen P. CareySVP & CFO | Open market sell$208K | -1.7% | $73.00 | $208K | Sep 29, 2026 | Sep 30, 2026 |
ANIP | Nikhil LalwaniPRESIDENT & CEO | Open market sell$383K | -1.6% | $71.00 | $383K | Sep 15, 2026 | Sep 16, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$35.4K | -0.7% | $70.79 | $35.4K | Sep 14, 2026 | Sep 14, 2026 |
ANIP | Jeanne ThomaDirector | Open market sell$71.5K | -3.6% | $71.53 | $71.5K | Sep 11, 2026 | Sep 14, 2026 |
ANIP | Stephen P. CareySVP & CFO | Open market sell$207K | -1.6% | $72.80 | $207K | Aug 31, 2026 | Sep 1, 2026 |
ANIP | Nikhil LalwaniPRESIDENT & CEO | Open market sell$401K | -1.5% | $74.30 | $401K | Aug 25, 2026 | Aug 26, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$37.7K | -0.7% | $75.48 | $37.7K | Aug 13, 2026 | Aug 13, 2026 |
ANIP | Ori GutwergSVP, GENERICS | Open market sell$243K | -4.0% | $77.00 | $243K | Aug 10, 2026 | Aug 11, 2026 |
ANIP | Stephen P. CareySVP & CFO | Open market sell$232K | -1.6% | $81.36 | $232K | Jul 29, 2026 | Jul 30, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$40.9K | -0.6% | $81.84 | $40.9K | Jul 13, 2026 | Jul 14, 2026 |
ANIP | Stephen P. CareySVP & CFO | Open market sell$240K | -1.6% | $84.12 | $240K | Jun 29, 2026 | Jun 30, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$41K | -0.6% | $82.03 | $41K | Jun 12, 2026 | Jun 15, 2026 |
ANIP | Thomas HaugheyDirector | Open market sell$162K | -4.9% | $80.88 | $162K | Jun 8, 2026 | Jun 10, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$39.1K | -0.6% | $78.16 | $39.1K | May 13, 2026 | May 13, 2026 |
ANIP | Patrick D. WalshDirector | Open market sell$806K | -20.7% | $80.63 | $806K | May 13, 2026 | May 13, 2026 |
ANIP | Ori GutwergSVP, GENERICS | Open market sell$220K | -3.4% | $79.50 | $220K | May 12, 2026 | May 13, 2026 |
ANIP | Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDS | Open market sell$36.4K | -1.2% | $79.21 | $36.4K | May 12, 2026 | May 13, 2026 |
ANIP | Nikhil LalwaniPRESIDENT & CEO | Open market sell$4.27M | -13.6% | $77.57 | $4.27M | May 11, 2026 | May 13, 2026 |
ANIP | Patrick D. WalshDirector | Open market sell$321K | -7.6% | $80.75 | $321K | May 11, 2026 | May 13, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$39K | -0.6% | $77.95 | $39K | Apr 13, 2026 | Apr 13, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$36.3K | -0.6% | $72.62 | $36.3K | Mar 13, 2026 | Mar 13, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$227K | -3.4% | $71.64 | $227K | Mar 13, 2026 | Mar 13, 2026 |
ANIP | Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDS | Open market sell$357K | -11.0% | $74.91 | $357K | Mar 11, 2026 | Mar 13, 2026 |
ANIP | Krista DavisSVP, CHIEF HR OFFICER | Open market sell$377K | -8.9% | $74.13 | $377K | Mar 9, 2026 | Mar 10, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$267K | -3.7% | $74.18 | $267K | Mar 9, 2026 | Mar 10, 2026 |
ANIP | Krista DavisSVP, CHIEF HR OFFICER | Open market sell$111K | -2.5% | $75.00 | $111K | Mar 6, 2026 | Mar 10, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$157K | -2.1% | $74.22 | $157K | Mar 6, 2026 | Mar 10, 2026 |
ANIP | Ori GutwergSVP, GENERICS | Open market sell$158K | -2.4% | $76.50 | $158K | Mar 3, 2026 | Mar 4, 2026 |
ANIP | Patrick D. WalshDirector | Open market sell$445K | -10.3% | $74.23 | $445K | Mar 3, 2026 | Mar 3, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$30.9K | -0.4% | $74.00 | $30.9K | Mar 2, 2026 | Mar 4, 2026 |
ANIP | Krista DavisSVP, CHIEF HR OFFICER | Open market sell$135K | -3.4% | $77.99 | $135K | Feb 20, 2026 | Feb 23, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$415K | -5.9% | $78.02 | $415K | Feb 20, 2026 | Feb 23, 2026 |
ANIP | Krista DavisSVP, CHIEF HR OFFICER | Open market sell$162K | -3.9% | $77.53 | $162K | Feb 19, 2026 | Feb 23, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$38.4K | -0.7% | $76.80 | $38.4K | Feb 13, 2026 | Feb 17, 2026 |
ANIP | Christopher MutzHEAD OF RARE DISEASE | Open market sell$538K | -7.1% | $76.55 | $538K | Feb 12, 2026 | Feb 17, 2026 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$42.2K | -0.7% | $84.33 | $42.2K | Jan 13, 2026 | Jan 14, 2026 |
ANIP | Krista DavisSVP, CHIEF HR OFFICER | Open market sell$134K | -2.7% | $82.40 | $134K | Dec 18, 2025 | Dec 19, 2025 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$32.9K | -0.5% | $82.32 | $32.9K | Dec 12, 2025 | Dec 12, 2025 |
ANIP | Renee P. TannenbaumDirector | Open market sell$146K | -6.7% | $81.15 | $146K | Dec 5, 2025 | Dec 9, 2025 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$34.9K | -0.5% | $87.27 | $34.9K | Nov 13, 2025 | Nov 14, 2025 |
ANIP | Chad GassertSVP - CORP. DEV. & STRATEGY | Open market sell$8.27K | 0.0% | $88.00 | $8.27K | Nov 13, 2025 | Nov 14, 2025 |
ANIP | Patrick D. WalshDirector | Open market sell$751K | -12.3% | $86.88 | $751K | Nov 13, 2025 | Nov 17, 2025 |
ANIP | Chad GassertSVP - CORP. DEV. & STRATEGY | Open market sell$1.3M | -5.9% | $89.07 | $1.3M | Nov 12, 2025 | Nov 14, 2025 |
ANIP | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Open market sell$36K | -0.5% | $90.09 | $36K | Oct 13, 2025 | Oct 14, 2025 |